| 000 | 01758 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517053649.0 | ||
| 264 | 0 | _c20170118 | |
| 008 | 201701s 0 0 eng d | ||
| 022 | _a1936-0541 | ||
| 024 | 7 |
_a10.1007/s12072-015-9662-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Chia-Chi | |
| 245 | 0 | 0 |
_aEfficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan. _h[electronic resource] |
| 260 |
_bHepatology international _cMar 2016 |
||
| 300 |
_a294-301 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTaiwan |
| 650 | 0 | 4 | _aTelbivudine |
| 650 | 0 | 4 |
_aThymidine _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aLin, Chih-Lin | |
| 700 | 1 | _aHsieh, Tsai-Yuan | |
| 700 | 1 | _aTseng, Kuo-Chih | |
| 700 | 1 | _aPeng, Cheng-Yuan | |
| 700 | 1 | _aSu, Tung-Hung | |
| 700 | 1 | _aYang, Sheng-Shun | |
| 700 | 1 | _aHsu, Yu-Chun | |
| 700 | 1 | _aChen, Tsung-Ming | |
| 700 | 1 | _aKao, Jia-Horng | |
| 773 | 0 |
_tHepatology international _gvol. 10 _gno. 2 _gp. 294-301 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12072-015-9662-9 _zAvailable from publisher's website |
| 999 |
_c25289269 _d25289269 |
||